A 2026 study reviewed by Gram Research analysis found that a body clock gene called NPAS2 helps protect the heart from diabetes damage. In diabetic mice, NPAS2 levels dropped, and restoring the gene improved heart function and reduced scarring and fat buildup.
Diabetes can weaken the heart muscle over time, a condition called diabetic cardiomyopathy. A 2026 study, reviewed by Gram Research analysis, found that a clock gene called NPAS2 appears to play a protective role. Diabetic mice had lower levels of this gene in their heart muscle, and the natural daily rhythm of the gene was disrupted. Mice without the gene in their hearts developed worse heart damage, including thickening and scarring. When researchers boosted NPAS2 in diabetic mice, their heart function improved and their blood fat and sugar levels moved closer to normal. The findings come from mice and heart cells grown in the lab, so they do not yet show the same effect in people.
Key Statistics
A 2026 study published in Frontiers in Cardiovascular Medicine found that diabetic mice had significantly lower levels of the NPAS2 gene in their heart muscle, along with a disrupted daily rhythm of its activity.
A 2026 mouse and heart cell study found that adding NPAS2 back to diabetic hearts reversed harmful changes, including reduced heart pumping, thickening, scarring, and fat buildup.
A 2026 laboratory study found that NPAS2 protected heart cells under high sugar and high fat conditions by maintaining the activity of the energy enzyme pyruvate dehydrogenase.
The Quick Take
- What they studied: Scientists wanted to know whether a body clock gene called NPAS2 helps protect the heart when a person has diabetes, and how it does so.
- Who participated: The study used diabetic mice, specially bred mice that lacked the gene in their heart muscle, and heart muscle cells grown in a lab dish. The exact number of animals and cell samples was not listed in the study summary.
- Key finding: Diabetic mice had less NPAS2 in their hearts, and their daily gene rhythm was disrupted. Mice lacking the gene had worse heart function, more thickening, more scarring, and more fat buildup. Adding NPAS2 back improved these problems.
- What it means for you: This research points to a possible new treatment target for diabetic heart disease, but it has not been tested in people. Anyone with diabetes should keep following their doctor’s advice on blood sugar, diet, exercise, and heart care.
The Research Details
The researchers first looked at heart muscle from diabetic mice and found that the NPAS2 gene was less active than normal and that its usual daily cycle was thrown off. Next, they bred mice that lacked NPAS2 only in their heart cells and fed them a high-fat diet combined with a drug that damages insulin-making cells, which is a common way to create diabetes in animals.
To look more closely at how the gene works, the team used a line of rat heart cells grown in the lab. They exposed these cells to high sugar and high fat conditions, then either turned down or boosted NPAS2 levels. They also changed the level of a key enzyme called pyruvate dehydrogenase, or PDH, to test whether PDH was the link between NPAS2 and heart health.
Finally, the researchers used a harmless delivery virus to add extra NPAS2 to the hearts of diabetic mice. They then measured heart pumping, heart wall thickness, scarring, fat levels, and blood sugar.
Using animals, lab cells, and a step-by-step approach let the researchers test cause and effect in ways that are not possible in people. By removing the gene, adding it back, and then changing PDH, they could show that NPAS2 works through a specific pathway, not just that the two happen to be linked.
The study used several connected experiments that support one another, which makes the overall story more convincing. However, the summary does not list exact group sizes, statistical details, or the number of repeated experiments, so readers cannot fully judge the strength of the numbers. Mouse and cell studies also often do not translate directly to human patients. The journal is a peer-reviewed publication, but it is not among the most widely read journals in medicine.
What the Results Show
The first major finding was that diabetic mice had less NPAS2 in their heart muscle, and the normal daily rise and fall of this gene was disrupted. This suggests that losing the body’s internal clock signals in the heart may be part of what goes wrong in diabetes.
Next, mice that lacked NPAS2 in their heart cells showed worse damage when they were made diabetic. Their hearts pumped less effectively, their heart walls thickened more, scar tissue built up, and fat accumulated in the heart muscle. This suggests the gene normally helps shield the heart from these changes.
In heart cells grown in the lab under high sugar and high fat conditions, reducing NPAS2 weakened the cells’ ability to produce energy in their mitochondria, which are the small power units inside cells. These cells also died more often and built up more fats. Increasing NPAS2 reversed these harmful effects.
The researchers then found that the gene appears to work through PDH. Boosting PDH reduced the damage caused by low NPAS2, while blocking PDH removed the benefits of extra NPAS2. This suggests PDH is a key step in how NPAS2 protects the heart.
When the researchers delivered extra NPAS2 to diabetic mice using a harmless virus, the benefits extended to the whole body. Blood fat and sugar levels moved closer to normal, and the heart showed better function with less thickening and scarring. This was seen in both normal diabetic mice and mice that lacked the gene in their hearts, suggesting the approach could work even when the natural gene is missing. These results point toward gene-based treatments, but they remain experimental.
Earlier research has linked disrupted body clock genes to obesity, diabetes, and heart problems. This study adds a more specific picture by showing that NPAS2 directly supports the energy machinery inside heart cells. It also builds on earlier evidence that diabetes harms the heart’s energy use, which is central to diabetic cardiomyopathy.
The most important limitation is that most of the evidence comes from mice and rat heart cells, which do not always respond to treatments the same way people do. The diabetes in the mice was created with a special diet and a drug, which may not fully match how diabetes develops in people over many years. The study also does not describe how long the benefits lasted or whether the treatment could be safely used in humans. Finally, the summary does not provide complete numerical details, so the size of the effects is not fully clear.
The Bottom Line
Based on this study alone, there is no recommendation for people to change their treatment or supplements. The findings are promising for researchers because they identify NPAS2 and PDH as possible targets for future heart treatments. Confidence in the basic biology is moderate, since several experiments point the same way. Confidence that this will become a treatment for people is currently low until human studies are done.
People with diabetes, especially those concerned about heart health, may find this research encouraging as a sign of future progress. Doctors, researchers, and drug developers working on heart complications of diabetes should pay close attention. People without diabetes or heart concerns do not need to act on these findings at this time.
Turning lab and animal discoveries into approved treatments usually takes many years. Early human safety studies would need to come first, followed by larger trials. People should not expect any new NPAS2-based treatment to be available in the near term.
Frequently Asked Questions
What is NPAS2 and how does it relate to heart health?
NPAS2 is a body clock gene that helps control daily rhythms in the body. A 2026 mouse study found it helps keep heart cells producing energy properly, and its levels dropped in diabetic mice, which was linked to more heart damage.
Can diabetes damage the heart even if blood sugar is controlled?
Diabetes can weaken the heart muscle through a condition called diabetic cardiomyopathy, which involves energy problems, fat buildup, and scarring in heart cells. Good blood sugar control, regular exercise, and medical checkups remain important steps for protecting heart health.
Does the NPAS2 study mean there is a new treatment for diabetic heart disease?
Not yet. The 2026 research was done in mice and lab-grown heart cells, showing that boosting NPAS2 improved heart function in those models. Human studies are needed before this approach could be considered a safe or effective treatment.
How can I support my body clock to help protect my heart with diabetes?
Keep consistent sleep and wake times, eat meals at similar times daily, and get regular physical activity. Research on body clock genes is still developing, so these habits should complement, not replace, your doctor’s diabetes and heart care plan.
Want to Apply This Research?
- Track fasting blood sugar, blood pressure, and resting heart rate at the same times each day for two to four weeks. Log the times you eat, sleep, and wake up, since these daily patterns are linked to the body clock that this study focuses on.
- Set a consistent sleep and wake time, including on weekends, and aim to eat meals at similar times each day. Pair this with a daily walk after a meal to support healthy blood sugar. These habits support the body’s natural daily rhythm and are widely recommended for diabetes care.
- Review your logs monthly and share trends with your doctor at regular checkups. Watch for changes in blood sugar control, blood pressure, swelling, or shortness of breath, and report them promptly. Continue to check the research news for updates on NPAS2 as human studies develop.
This article summarizes a laboratory and animal research study and is for general information only. The findings have not yet been tested in people, and they should not be used to start, stop, or change any medication, supplement, or diabetes or heart treatment. Please talk with your doctor or cardiologist before making any changes to your health care plan.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.